Accor: Oddo raises target price
(CercleFinance.com) - Oddo maintains its buy rating on the Accor share, believing that, in the near term, the group should benefit from the Covid-19 vaccine with a strong recovery in leisure travel from the end of the first half of 2021.
According to the analyst, Accor also has "solid fundamentals," with cash of over 4 billion euros at the end of September and a cost savings plan. As a result, Oddo has raised its target price for the share to 32.5 euros from 28 euros previously. The market seems to agree, with the share currently up over 3% at just over 29 euros.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
According to the analyst, Accor also has "solid fundamentals," with cash of over 4 billion euros at the end of September and a cost savings plan. As a result, Oddo has raised its target price for the share to 32.5 euros from 28 euros previously. The market seems to agree, with the share currently up over 3% at just over 29 euros.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.